Inclusion Criteria:

- APD patient ≥ 18 years

- Prevalent patient with at least 3 months experience on APD prior to inclusion

- Patient is trained on and being treated with the sleep•safe APD cycler

- Patient treated on APD exclusively with registered conventional PD solutions CAPD 2,
CAPD 3, CAPD 4, CAPD 17, CAPD 18 or CAPD 19 for at least 8 weeks prior to inclusion

- Patient is on stable diuretic treatment e.g no change in diuretic treatment within
the last 30 days prior to inclusion

- Informed consent signed and dated by study patient and investigator/authorised
physician

- Ability to understand the nature and requirements of the study

Exclusion Criteria:

- Peritonitis treatment £ 4 weeks preceding inclusion

- APD patients treated with IPD modality (intermittent peritoneal dialysis)

- Malignant disease without remission

- Patients with artificial joints, amputations, stents, or pacemaker

- Patients with congestive heart failure or coronary artery disease NYHA (New York
Heart Association) III and higher

- Active HBV (hepatitis B virus)or HCV(hepatitis C virus)infection- HIV positive

- Participation in an interventional clinical study during the preceding 30 days

- Any condition which could interfere with the patient's ability to comply with the
study